HALISTER: PharMerica to Be Acquired by KKR in Deal Valued at $1.4B

PharMerica to Be Acquired by KKR in Deal Valued at $1.4B

(Bloomberg) -- PharMerica to be bought by newly formed company controlled by KKR, with Walgreens Boots Alliance for $29.25/shr in cash.
  • Walgreens Boots Alliance to have minority equity stake in new company
  • KKR making investment primarily through Americas XII Fund
  • Fully committed debt financing to be provided by Goldman
  • Sachs, Morgan Stanley, Wells Fargo, Jefferies and KKR Capital Markets
  • Price represents premium 17% to closing share price as of last trading day prior to announcement
  • PharMerica financial advisers are UBS Investment Bank and BofA Merrill Lynch
  • PharMerica also reports 2Q adj eps 47c matching analyst estimate
  • PMC shares halted
Link to Statement: PharMerica Corporation Enters into Definitive Agreement to Be Acquired by KKR for $29.25 per Share in Cash Link to Earnings Statement: PharMerica Reports Second Quarter 2017 Results To contact the reporter on this story: Kimberly Yuen in New York at kyuen3@bloomberg.net

Alert: HALISTER
Source: BFW (Bloomberg First Word)

Tickers
KKR US (KKR & Co LP)
PMC US (PharMerica Corp)
WBA US (Walgreens Boots Alliance Inc)

To de-activate this alert, click here
To modify this alert, click here

UUID: 7947283